search
Back to results

Motivational Support Program in Chronic Low Back Pain After Multidisciplinary Functional Rehabilitation (EMOTIV)

Primary Purpose

Chronic Low-back Pain

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Motivational Support Program Emotiv
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Low-back Pain focused on measuring Chronic Low-back Pain, Multidisciplinary function rehabilitation, Motivational Support Program Emotiv

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: age 18 or over Disabling chronic low back pain: chronic painful patient, that is to say suffering from pain for more than 3 months, having interrupted all physical and professional activity because of low back pain. Having reached the end of an FRP program Possession of a smartphone Fluency in French (writing, reading) Health insurance coverage (beneficiary or beneficiary) except State Medical Aid. Patient Informed Consent Signature Exclusion Criteria: Pregnant woman Patient refusal Patient deprived of liberty and patient under legal protection measure (guardianship, guardianship) Patient participating to another interventional search

Sites / Locations

  • Hôpital Pitié SalpêtrièreRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Standard arm

Motivational Support Program Emotiv

Arm Description

The patients will have the usual care

The patients will have the motivational support program

Outcomes

Primary Outcome Measures

Difference in disability and pain between the experimental (SHP) and control (usual care) groups, measured with the Core Outcome Measure Index (COMI) scale at 12 months.
The Core Outcome Measure Index (COMI) was developed from requirements of international back pain experts. According to European experts, the COMI should currently be recommended in assessment of chronic low back pain. This questionnaire assesses pain and disability in low back pain. It includes 9 items and its score is between 0 and 10. Higher scores is the worse outcome.

Secondary Outcome Measures

Evolution of pain
Pain will be measured by a Visual Analogic Scale (VAS) with a question about lumbar pain over the last 7 days. Minimum and maximum values are 0 and 100.
Evolution of flexibility
Flexibility will be evaluated by measuring the hand-to-ground distance
Evolution of muscular endurance
Muscular endurance will be assessed by measuring Shirado (abdominal endurance). Its score is between 0 and no limit. 0 is the worse outcome.
Evolution of muscular endurance
Muscular endurance will be assessed by measuring Sorensen (spinal extensor endurance). Its score is between 0 and no limit. 0 is the worse outcome.
Evolution of disability and pain
Disability and pain will be assessed by the Core Outcome Measure Index (COMI) questionnaire. Its score is between 0 and 10. Higher scores is the worse outcome.
Evolution of endurance and sports performance (VO2 max)
Endurance and sports performance will be assessed on the treadmill
Evolution of the intensity of physical activity
Intensity of physical activity will be assessed by the IPAQ (International Physical Activity Questionnaire). Scoring a high level of physical activity on the IPAQ means the physical activity levels equate to approximately one hour of activity per day or more at least a moderate intensity activity level.
Evolution of muscular trophicity in the 2 groups
Muscular trophicity will be done by the measurement of the cross-sectional area (CSA) of the extensor muscles at the level of the upper and lower plateaus of L4 at the lumbar spine
Evolution of the level of anxiety and depression
Level of anxiety and depression will be assessed by the HAD (Hospital Anxiety and Depression) scale. 14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and seven others to the depressive dimension (total D), thus allowing two scores (maximum and worse of each score equal 21)
Evolution of the level of central pain awareness
Two parameters will be used, in accordance with international recommendations on Quantitative Sensory Testings : the pain pressure threshold using an algometer, at a distance from the painful area (forearm), and the temporal summation by repeating a painful stimulus with a calibrated needle (PinPrick)
Medico-economic analysis
The elements for the medico-economic analysis will be collected on the basis of a questionnaire validated in French. The data collected are : - consultations in general medicine and rheumatology as part of the usual follow-up of patients, - biological or imaging examinations carried out for the spinal problem, - medicinal treatments (drugs, infiltrative procedures) and non-medicinal treatments (physiotherapy, others) carried out for the spinal problem, - any hospitalizations related to the spinal problem
Cost of care (i.e, health resource use and related costs or direct costs)
Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued on the basis of the tariffs of the National Health Insurance Fund (CNAM). Health resource use related costs will be expressed in Euros
Cost of care (i.e, health resource use and related costs or direct costs)
Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued using data from the Common Classification of Medical Acts (CCAM). Health resource use related costs will be expressed in Euros
Cost of care (i.e, health resource use and related costs or direct costs)
Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued using data from the Nomenclature of Medical Biology Acts (NABM). Health resource use related costs will be expressed in Euros
Cost of care (i.e, health resource use and related costs or direct costs)
Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued using data from the national scale of costs (ENC) for hospitalisations. Health resource use related costs will be expressed in Euros
Sick leave days
The number of working days off work will be elicited
Productivity loss (i.e, sick leave-related costs or indirect costs)
Sick leave days will be valued on the basis of the average daily salaries published each year by the French National Institute of Statistics (INSEE, www.insee.fr). It will be expressed in Euros.
Satisfaction with the program
Satisfaction with the program will be measured by a Visual Analogic Scale (VAS). Minimum and maximum values are 0 and 100. The better score is 100.
Adherence to the program
Adherence to the program will be evaluated on the number of connection (minimum value 0 and no maximum)
Adherence to the program
Adherence to the program will be evaluated on the time of connection (minimum value 0 and no maximum)
Adherence to the program
Adherence to the program will be evaluated on number of reminders necessary by the coordinator in case of non connection and/or non attendance at the follow-up (minimum value 0 and non maximum)

Full Information

First Posted
January 23, 2023
Last Updated
October 16, 2023
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT05780021
Brief Title
Motivational Support Program in Chronic Low Back Pain After Multidisciplinary Functional Rehabilitation
Acronym
EMOTIV
Official Title
Evaluation of the Effectiveness of a MOTIVational Support Program After Multidisciplinary Functional Rehabilitation in Chronic Low Back Pain
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 26, 2023 (Actual)
Primary Completion Date
September 26, 2025 (Anticipated)
Study Completion Date
September 26, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Chronic low back pain (CLBP) is a major public health problem. Multidisciplinary functional rehabilitation program (FRP), which give patients the skills to better manage pain and return to physical activity, are effective in the short term. In the medium and long term, due to lack of motivation, two thirds of patients stop their physical activity again, causing them to fall back into the vicious circle of pain. Investigators hypothesise that a remote assessment and motivational support program (MSP) based on an application, piloted by a care coordinator, could allow the continued improvement of symptoms and activities observed after the FRP programs, and thus limit the consequences of CLBP for the patient and society. The main objective of this study is to evaluate the effect of the motivational support program EMOTIV, on disability and pain at one year, in chronic low back pain patients who have benefited from a FRP program.
Detailed Description
Multidisciplinary functional rehabilitation program (FRP) have shown their efficacy in disabilitie patient suffering from Chronic low back pain (CLBP). Unfortunately, at medium and long term two thirds of patients stop their physical activity due to lack of motivation. These patients then fall back into their painful vicious circle. Investigators hypothesis that motivational support program (MSP) based on an application, piloted by a care coordinator could increase the motivation to continue physical activity and thus limit the consequences of CLBP for the patient and society. The main objective is to evaluate the impact of a MSP (EMOTIV) on pain and functional abilities assessed according to the COMI scale (Core Outcome Measure Index), 12 months after a FRP in patients with LPBC. This program is compared to usual care as currently done. The secondary criteria concern: physical, neuropsychological and medico-economical criteria. This is a multicentre, cluster randomized trial. All adult patient suffering from low back pain, having finished a FRP and possessing a smartphone, will be included. Investigators plan to include 150 patients in 6 centres. The duration of the inclusion period is 12 months; The duration of participation of each subject is 24 months. Inclusion will be on the last day of the FRP program. The Follow-up in consultation is scheduled at 3, 12 and 24 months with evaluation of usual criteria (physical, self-questionnaires, and advice on the practice of physical activities depending on what is achieved). In Pitie salpetriere center only, patients will have in addition: lumbar MRI at 3 and 12 months; central pain awareness assessment. The activity of patients in the MSP group will be recorded continuously par EMOTIV App; pain, mental health and days off every week and self-questionnaires at 1, 2 and 6 months. The primary analysis of all endpoints will be performed in the intent-to-treat population, i.e. all patients randomized to the study. The COMI score will be compared between the 2 randomized groups by a linear mixed model.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Low-back Pain
Keywords
Chronic Low-back Pain, Multidisciplinary function rehabilitation, Motivational Support Program Emotiv

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
150 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard arm
Arm Type
No Intervention
Arm Description
The patients will have the usual care
Arm Title
Motivational Support Program Emotiv
Arm Type
Experimental
Arm Description
The patients will have the motivational support program
Intervention Type
Behavioral
Intervention Name(s)
Motivational Support Program Emotiv
Intervention Description
A motivational support program including a motivational and self-assessment remote application in the form of a Smartphone application for chronic low back pain patients after multidisciplinary functional rehabilitation.
Primary Outcome Measure Information:
Title
Difference in disability and pain between the experimental (SHP) and control (usual care) groups, measured with the Core Outcome Measure Index (COMI) scale at 12 months.
Description
The Core Outcome Measure Index (COMI) was developed from requirements of international back pain experts. According to European experts, the COMI should currently be recommended in assessment of chronic low back pain. This questionnaire assesses pain and disability in low back pain. It includes 9 items and its score is between 0 and 10. Higher scores is the worse outcome.
Time Frame
12 months after completion of the multidisciplinary functional rehabilitation program
Secondary Outcome Measure Information:
Title
Evolution of pain
Description
Pain will be measured by a Visual Analogic Scale (VAS) with a question about lumbar pain over the last 7 days. Minimum and maximum values are 0 and 100.
Time Frame
At 3 months, 12 months and 24 months
Title
Evolution of flexibility
Description
Flexibility will be evaluated by measuring the hand-to-ground distance
Time Frame
At 3 months, 12 months and 24 months
Title
Evolution of muscular endurance
Description
Muscular endurance will be assessed by measuring Shirado (abdominal endurance). Its score is between 0 and no limit. 0 is the worse outcome.
Time Frame
At 3 months, 12 months and 24 months
Title
Evolution of muscular endurance
Description
Muscular endurance will be assessed by measuring Sorensen (spinal extensor endurance). Its score is between 0 and no limit. 0 is the worse outcome.
Time Frame
At 3 months, 12 months and 24 months
Title
Evolution of disability and pain
Description
Disability and pain will be assessed by the Core Outcome Measure Index (COMI) questionnaire. Its score is between 0 and 10. Higher scores is the worse outcome.
Time Frame
At 3 months, 12 months and 24 months
Title
Evolution of endurance and sports performance (VO2 max)
Description
Endurance and sports performance will be assessed on the treadmill
Time Frame
At 3 months, 12 months and 24 months
Title
Evolution of the intensity of physical activity
Description
Intensity of physical activity will be assessed by the IPAQ (International Physical Activity Questionnaire). Scoring a high level of physical activity on the IPAQ means the physical activity levels equate to approximately one hour of activity per day or more at least a moderate intensity activity level.
Time Frame
At 3 months, 12 months and 24 months
Title
Evolution of muscular trophicity in the 2 groups
Description
Muscular trophicity will be done by the measurement of the cross-sectional area (CSA) of the extensor muscles at the level of the upper and lower plateaus of L4 at the lumbar spine
Time Frame
At 3 months and 12 months
Title
Evolution of the level of anxiety and depression
Description
Level of anxiety and depression will be assessed by the HAD (Hospital Anxiety and Depression) scale. 14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and seven others to the depressive dimension (total D), thus allowing two scores (maximum and worse of each score equal 21)
Time Frame
At 3 months, 12 months and 24 months
Title
Evolution of the level of central pain awareness
Description
Two parameters will be used, in accordance with international recommendations on Quantitative Sensory Testings : the pain pressure threshold using an algometer, at a distance from the painful area (forearm), and the temporal summation by repeating a painful stimulus with a calibrated needle (PinPrick)
Time Frame
At inclusion, 3 months, 12 months and 24 months
Title
Medico-economic analysis
Description
The elements for the medico-economic analysis will be collected on the basis of a questionnaire validated in French. The data collected are : - consultations in general medicine and rheumatology as part of the usual follow-up of patients, - biological or imaging examinations carried out for the spinal problem, - medicinal treatments (drugs, infiltrative procedures) and non-medicinal treatments (physiotherapy, others) carried out for the spinal problem, - any hospitalizations related to the spinal problem
Time Frame
At 3 months, 12 months and 24 months
Title
Cost of care (i.e, health resource use and related costs or direct costs)
Description
Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued on the basis of the tariffs of the National Health Insurance Fund (CNAM). Health resource use related costs will be expressed in Euros
Time Frame
At 3 months, 12 months and 24 months
Title
Cost of care (i.e, health resource use and related costs or direct costs)
Description
Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued using data from the Common Classification of Medical Acts (CCAM). Health resource use related costs will be expressed in Euros
Time Frame
At 3 months, 12 months and 24 months
Title
Cost of care (i.e, health resource use and related costs or direct costs)
Description
Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued using data from the Nomenclature of Medical Biology Acts (NABM). Health resource use related costs will be expressed in Euros
Time Frame
At 3 months, 12 months and 24 months
Title
Cost of care (i.e, health resource use and related costs or direct costs)
Description
Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued using data from the national scale of costs (ENC) for hospitalisations. Health resource use related costs will be expressed in Euros
Time Frame
At 3 months, 12 months and 24 months
Title
Sick leave days
Description
The number of working days off work will be elicited
Time Frame
At 3 months, 12 months and 24 months
Title
Productivity loss (i.e, sick leave-related costs or indirect costs)
Description
Sick leave days will be valued on the basis of the average daily salaries published each year by the French National Institute of Statistics (INSEE, www.insee.fr). It will be expressed in Euros.
Time Frame
At 3 months, 12 months and 24 months
Title
Satisfaction with the program
Description
Satisfaction with the program will be measured by a Visual Analogic Scale (VAS). Minimum and maximum values are 0 and 100. The better score is 100.
Time Frame
At 3 months, 12 months and 24 months
Title
Adherence to the program
Description
Adherence to the program will be evaluated on the number of connection (minimum value 0 and no maximum)
Time Frame
At 3 months, 12 months and 24 months
Title
Adherence to the program
Description
Adherence to the program will be evaluated on the time of connection (minimum value 0 and no maximum)
Time Frame
At 3 months, 12 months and 24 months
Title
Adherence to the program
Description
Adherence to the program will be evaluated on number of reminders necessary by the coordinator in case of non connection and/or non attendance at the follow-up (minimum value 0 and non maximum)
Time Frame
At 3 months, 12 months and 24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age 18 or over Disabling chronic low back pain: chronic painful patient, that is to say suffering from pain for more than 3 months, having interrupted all physical and professional activity because of low back pain. Having reached the end of an FRP program Possession of a smartphone Fluency in French (writing, reading) Health insurance coverage (beneficiary or beneficiary) except State Medical Aid. Patient Informed Consent Signature Exclusion Criteria: Pregnant woman Patient refusal Patient deprived of liberty and patient under legal protection measure (guardianship, guardianship) Patient participating to another interventional search
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Violaine FOLTZ, Dr
Phone
01 42 17 79 58
Email
violaine.foltz@aphp.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Bruno FAUTREL, Pr
Phone
01 42 17 78 01
Email
bruno.fautrel@aphp.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Violaine FOLTZ, Dr
Organizational Affiliation
Hôpital Pitié Salpêtrière - Assistance Publique Hôpitaux de Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hôpital Pitié Salpêtrière
City
Paris
ZIP/Postal Code
75013
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Violaine FOLTZ, Dr
Phone
01 42 17 79 58
Email
violaine.foltz@aphp.fr

12. IPD Sharing Statement

Learn more about this trial

Motivational Support Program in Chronic Low Back Pain After Multidisciplinary Functional Rehabilitation

We'll reach out to this number within 24 hrs